Retatrutide, by Soma, represents a exciting breakthrough in weight control . This dual-action compound combines hormonal signaling activity with gut-derived receptor agonist engagement, showing impressive potential in trial data for metabolic improvement. Researchers believe the drug could represent a new pathway for patients experiencing excess we